Identification of AEG-1 and BARD1 as predictors of erlotinib outcome in EGFR-mutant non-small cell lung cancer (NSCLC) by NanoString multiple target profiling.
暂无分享，去创建一个
M. Taron | M. Santarpia | S. Benlloch | C. Camps | C. Queralt | E. Carcereny | T. Morán | D. Isla | I. de Aguirre | M. Molina | M. Majem | S. Viteri | C. Costa | R. Rosell | J. Bertran-Alamillo | C. Mayo | A. Gascó | J. Sánchez | B. Massutí | A. Gimenez Capitan